The role of pharmaceutical intermediates buyers is fraught with challenges. One significant issue is the volatility of the raw materials market. Prices can fluctuate due to geopolitical tensions, supply chain disruptions, or even natural disasters. Buyers must be adept at risk management and contingency planning to mitigate these risks while ensuring that their company remains competitive.
Sevoflurane is a halogenated ether that is odorless, non-irritating, and highly soluble in fat, which translates to its ability to facilitate rapid induction and emergence from anesthesia. Its low blood-gas partition coefficient (approximately 0.69) allows for quick changes in anesthetic depth, as the agent equilibrates swiftly with the central nervous system. This characteristic is especially beneficial in outpatient settings where speedy recovery is desired.
When we consider the price of isoflurane in a 250ml quantity, it is important to note that costs might fluctuate based on several variables. On average, the price for a 250ml bottle can range from approximately $100 to $300. The variability can be attributed to wholesale pricing agreements, regional differences, and supply chain issues. Licensing and regulatory factors also play a crucial role, as only certain manufacturers can distribute isoflurane based on stringent pharmaceutical regulations.